MPO and type 2 diabetes mellitus: In particular, a significant increase in serum MPO-DNA complexes (p < 0.0001) was observed in patients with type II diabetes who also have diabetic kidney disease when compared to control subjects (patients with type II diabetes without diabetic kidney disease).